Article
Combination of polymorphisms in the beta2-adrenergic receptor and nitric oxide synthase 3 genes increases the risk for hypertension.
Journal of hypertension - 1 Jul 2009
Misono Maiko, Maeda Seiji, Iemitsu Motoyuki, Nakata Yoshio, Otsuki Takeshi, Sugawara Jun, Zempo Hirofumi, Yoshizawa Mutsuko, Miyaki Asako, Kuno Shinya, Matsuda Mitsuo, Ajisaka Ryuichi
Abstract excerpt
OBJECTIVE: Hypertension is a major risk factor for cardiovascular disease. Polymorphism in the beta2-adrenergic receptor (ADRB2) and nitric oxide synthase 3 (NOS3) genes is associated with clinical cardiovascular phenotypes. The Arg16Gly and Glu298Asp polymorphisms of ADRB2 and NOS3 genes, respectively, have been reported to be associated with hypertension. We hypothesized that a combination of these two...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
